Comparison
Saffron vs Muira Puama
Saffron
Crocus stigma — most expensive spice. Increasingly evidence-based antidepressant comparable to SSRIs at low doses.
Muira Puama
Amazonian root (Ptychopetalum olacoides) traditionally used for libido and cognitive support. Limited Western evidence.
| Field | Saffron | Muira Puama |
|---|---|---|
| Category | adaptogen | adaptogen |
| Dose range | 28–30mg | 1000–1500mg |
| Half-life | — | — |
| Onset | — | — |
| Evidence | EVIDENCEA | EVIDENCEC |
| Safety | ●●●●○ | ●●●●○ |
| Legal (US) | USOTC | USOTC |
| PubMed refs | 1700 | 80 |
The comparison in plain English
Auto-generated from dataSaffron and Muira Puama are both in the adaptogen category respectively. Saffron Crocus stigma — most expensive spice. Muira Puama Amazonian root (Ptychopetalum olacoides) traditionally used for libido and cognitive support.
Bottom line
Saffron (evidence A, safety 4/5) has a weaker evidence base than Muira Puama (evidence C, safety 4/5). Saffron has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.
Choose Saffron if
Saffron is the better fit when your goal aligns with its mechanism (Crocin (carotenoid responsible for the red colour) and safranal (volatile compound responsible for the aroma) both inhibit serotonin and dopamine reuptake at neurochemically meaningful concentrations) and the dose range (28–30mg) suits your protocol. Half-life is —h.
Choose Muira Puama if
Muira Puama is the better fit when your goal aligns with its mechanism (Multiple bioactive compounds including alkaloids, lupeol, beta-sitosterol) and the dose range (1000–1500mg) suits your protocol. Half-life is —h.